As we approach 2014, we would like to take this opportunity to thank our Editors, Reviewers, Authors and Journal Sponsors for their valuable contribut

Revolade banner 728x90 R1

As we approach 2014, we would like to take this opportunity to thank our Editors, Reviewers, Authors and Journal Sponsors for their valuable contribution to the journal.

2013 was an exciting year for the journal, as highlighted by:

• Record number of submissions – as of December 2nd, we had 436 submissions to the journal; over a 50% increase from 2012!

• Increase in visitors to - Recent stats from Google Analytics, Google’s web site traffic analysis application, have shown over a 15% increase in the number of visitors to the website over the past year

• An article published in Current Oncology, Volume 20, Number 4 (August 2013) received National attention. The National Post interviewed Dr. David Palma who is one of the authors of the article entitled “The epidemic of human papillomavirus and oropharyngeal cancer in a Canadian population”,regarding the findings presented in the article. CTV Toronto later interviewed Dr. Palma live.

o Click here to read the article published in Current Oncology
o Click here to read the article published in the National Post
o Click here to watch the interview

We look forward to continued success in 2014 as the journal continues to strengthen and grow!

Best wishes for a happy holiday season,


Multimed Inc.
Publisher of Current Oncology

CO Twitter Banner Ad

Lessons Learned from PAAB Conference

On October 24th, I attended a conference held by PAAB (the Pharmaceutical Advertising Advisory Board) for Canada about how to create compliant multi-channel marketing campaigns. The PAAB is an independent review agency whose primary role is to ensure that healthcare product communication for prescription, non-prescription, biological and natural health products is accurate, balanced and evidence-based, and reflects current and best practice.

During the conference, I learned more about this organization, creating compliant ad campaigns and where advertising is heading in the future. One interesting session was presented by Regina Kulikowski from the Canadian Association of Medical Publishers. This session focused on navigating digital and print in the challenging new landscape of marketing.

There are some interesting facts I learned from this session that is pertinent to publishing:

• Print journals rank #2 as a valuable source of information for patient treatment and prescription products – (#1 rank is Continuing Medial Information meetings)
• Journal readership has increased 16% since 2011
• Physicians spend an average of eleven hours online for professional purposes per week
• 52% of web visits are less than 10 seconds
• Average reading time for academic paper:
       o Hard copy (22-45 minutes) vs Online copy (74 seconds)
• Top advertising is “reminder advertising” compared to “informative advertising” and “persuasive advertising”

I found the conference quite informative and I hope you find my findings useful for your own advertising endeavors.

Amanda Shand,
Project Coordinator, Multimed Inc.


Volume 20, Number 6 (December 2013)

The latest issue of Current Oncology is now available online. Please visit the following link to view full text articles from this issue:


Upcoming in Current Oncology

The future table of contents for Current Oncology, Volume 21, Number 1 (February 2013) is now available. For the most up-to-date listing of scheduled papers, please visit the following link:

Eva office 2012 best

Dr. Eva Grunfeld, MD, DPhil
Editor of our Knowledge Translation Section (since December 2010)

Dr. Eva Grunfeld is a physician scientist with the Ontario Institute for Cancer Research and the Vice-Chair Research for the Department of Family and Community Medicine at the University of Toronto. She completed her undergraduate medical training at McMaster University, and a doctoral training in cancer epidemiology at Oxford University. She was Associate Professor and clinician scientist at the Ottawa Regional Cancer Centre, senior scientist with the Ottawa Health Research Institute, and held an Ontario Ministry of Health and Long-term Care career scientist award from 1995 to 2004. In 2004 she moved to Nova Scotia to create the Cancer Outcomes Research program at Cancer Care Nova Scotia and Dalhousie University. While in Nova Scotia held the Cameron Chair in Cancer Control Research; a Clinical Research Scholar Award; and the Peggy Davison Award for Health Services Research. In 2008 she moved to the University of Toronto to take up her current positions.

Dr. Grunfeld’s research focuses on cancer health services and knowledge translation (KT). To further the goals of KT relevant to cancer control, she proposed the creation of a special section on KT in Current Oncology. The section was launched with an editorial in 2011. She continues in her role as section editor and welcomes manuscripts which meet the special criteria developed for this section.

To view the most recent article from the Knowledge Translation section, please click here.


Congratulations to our Deputy Editor – Dr. Phil Gold for winning the 2013 Prix du Québec award!

Dr. Gold will be awarded the Wilder-Penfield Prize for his work in the ground-breaking discovery of the carcinoembryonic antigen (CEA).

The CEA was discovered in 1965 by Dr. Gold and his colleague, Samuel Freedman. This discovery revolutionized cancer research and is now the most frequently used blood test in modern oncology. The discovery of the CEA also launched the field of oncodevelopmental biology.

Thank you for your important contribution to oncology, Dr. Gold!

Phil-Gold cropped11-253x300

Have you had the chance to view these Current Oncology “Most-Read” articles?

Most Read Articles in PubMed Central (November 2013)

Legalizing euthanasia or assisted suicide: the illusion of safeguards and controls
Pereira J.
Curr Oncol. 2011 Apr;18(2):e38-45

Prophylaxis and management of acute radiation-induced skin reactions: a systematic review of the literature
Salvo N, Barnes E, van Draanen J, Stacey E, Mitera G, Breen D, Giotis A, Czarnota G, Pang J, De Angelis C.
Curr Oncol. 2010 Aug;17(4):94-112

Management of skin rash during EGFR-targeted monoclonal antibody treatment for gastrointestinal malignancies: Canadian recommendations
Melosky B, Burkes R, Rayson D, Alcindor T, Shear N, Lacouture M
Curr Oncol. 2009 Jan;16(1):16-26

Most Read Recently* Published Articles at

Genetically modified foods, cancer, and diet: myths and reality
Touyz L.Z.G.
Curr Oncol. 2013 Apr; 20(2):e59-e61

Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer
Morgillo F., De Vita F., Antoniol G., Orditura M., Auriemma P.P., Diadema M.R., Lieto E., Savastano B., Festino L., Laterza M.M., Fabozzi A., Ventriglia J., Petrillo A., Ciardiello F., Barbarisi A., Iovino F.
Curr Oncol. 2013 Aug; 20(4):e283-e288

Bevacizumab-based therapy for colorectal cancer: experience from a large Canadian cohort at the Jewish General Hospital between 2004 and 2009
N. Bouganim, A. Mamo, D.W. Wasserman, G. Batist, P. Metrakos, P. Chaudhury, M. Hassanain, P. Kavan
Curr Oncol. 2013 Oct;20(5):247-251

*Published within past 12 months


Contact Us